Mid-Day Report
The markets extended its losses during the midday with the Dow skidding 292 points to 10,767 as investors digested the govenment's $85 billion bailout of AIG. Nasdaq stumbled 70 points to 2138.
On the upside
The Food and Drug Administration approved Mylan's (NYSE: MYL) generic version of Johnson & Johnson's (NYSE: JNJ) bipolar disorder and schizophrenia treatment Risperdal.
Citigroup analyst Timothy Arcuri upgraded Evergreen Solar (Nasdaq: ESLR) while lowering his earnings outlook after the solar power products company clarified its exposure to bankrupt Lehman Brothers.
On the downside
Nortel Networks (NYSE: NT) blamed the global economic slowdown for lowering its fiscal 2008 guidance.
Canadian rating agency DBRS lowered its rating on Morgan Stanley (NYSE: MS) to negative citing earnings pressure due to turmoil in the financial services sector.
In the broad market, declining issues outpaced advancers by a margin of more than 13 to 1 on the NYSE and by more than 5 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks plummeted 31 points to 680.

